3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Cisplatin
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
pembrolizumab
6
durvalumab
6
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
cemiplimab
5
Carboplatin
5
Radiation
4
Cetuximab
4
Biopsy
4
poly ICLC
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Pemetrexed
3
Paclitaxel
3
Nivolumab
3
Docetaxel
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
cabozantinib
2
atezolizumab
2
Oxaliplatin
2
Ipilimumab
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
Capecitabine
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
tislelizumab
×
30 days
×
Clear all
No trials found.